Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Operating Expenses: 2013-2018

Historic Operating Expenses for Astria Therapeutics (ATXS) over the last 6 years, with Dec 2018 value amounting to $26.4 million.

  • Astria Therapeutics' Operating Expenses rose 6.58% to $6.1 million in Q4 2018 from the same period last year, while for Dec 2018 it was $26.4 million, marking a year-over-year decrease of 4.43%. This contributed to the annual value of $26.4 million for FY2018, which is 4.43% down from last year.
  • According to the latest figures from FY2018, Astria Therapeutics' Operating Expenses is $26.4 million, which was down 4.43% from $27.6 million recorded in FY2017.
  • In the past 5 years, Astria Therapeutics' Operating Expenses registered a high of $35.6 million during FY2016, and its lowest value of $21.7 million during FY2014.
  • Moreover, its 3-year median value for Operating Expenses was $27.6 million (2017), whereas its average is $29.8 million.
  • In the last 5 years, Astria Therapeutics' Operating Expenses spiked by 46.02% in 2015 and then dropped by 22.40% in 2017.
  • Over the past 5 years, Astria Therapeutics' Operating Expenses (Yearly) stood at $21.7 million in 2014, then skyrocketed by 46.02% to $31.7 million in 2015, then grew by 12.32% to $35.6 million in 2016, then decreased by 22.40% to $27.6 million in 2017, then dropped by 4.43% to $26.4 million in 2018.